HBAN
VC Fund
Dublin, Ireland
HBAN is an all-island umbrella group responsible for the development of business angel syndicates. HBAN actively works to increase the number of angel investors involved in investing in early stage companies and supports the formation of new and existing angel networks, both regionally and internationally, and within industry sectors.Despitethe economic tsunami, the growth in Irish business angel investment in recent times has been significant. In 2014 HBAN business angels, across the island invested €9 million into 48 companies. This direct angel investment leveraged a further €20M of additional public & private funds into these companies from organisations such as Enterprise Ireland, venture capital companies and founders. These numbers have risen steadily from 2011 when HBAN helped 29 companies raise €12m of which €6m came from angel investors.
- Total investments:
- 71
- Last investment:
- Lead investor:
- 34%
- Fund size:
- $10M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries HBAN invests in
Stages HBAN invests in
Countries HBAN invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $623k–$3.5M
- Series A
- $1.2M–$9.2M
Investment Focus
Industry
- Software 12 (17%)
- Health Care 11 (15%)
- Medical Device 9 (13%)
- Information Technology 9 (13%)
- Medical 6 (8%)
Stage
- Seed 36 (51%)
- Funding Round 14 (20%)
- Series A 6 (8%)
- Pre-Seed 4 (6%)
- Angel 2 (3%)
Country
- Ireland 38 (54%)
- United Kingdom 14 (20%)
- United States 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Anthony Bermingham
Investor
|
Investor | Total investments: 0 | Find email | |
Brendan McKittrick
Chairman
|
Chairman | Total investments: 0 | Find email | |
John Phelan
National Director
|
National Director | Total investments: 0 | Find email | |
John Phelan
National Director
|
National Director | Total investments: 2 | Find email | |
Lucy Daly
Operations Associate
|
Operations Associate | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Glitch Ads
|
GlitchAds intends to democratize advertising by "leveraging" adverts and artificial intelligence. | $2.3M / Seed / Nov 11, 2025 | |
Movetru
|
Movetru a wearable device that aims to reduce injury and enhance rehabilitation. | $1.6M / Pre-Seed / Jul 08, 2025 | |
Change by Degrees
|
Change by degrees supports individuals and organizations in developing sustainable competencies and gaining self-assurance to achieve sustainability goals, expand their businesses, and adhere to legal requirements. | $734K / Seed / Mar 03, 2025 | |
|
Change by Degrees
|
Change by degrees supports individuals and organizations in developing sustainable competencies and gaining self-assurance to achieve sustainability goals, expand their businesses, and adhere to legal requirements. | $734K / Seed / Mar 03, 2025 | |
Ovagen
|
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics. | $2.2M / Series A / Oct 29, 2024 | |
Educatly
|
We help you get into the University of your dreams. We are the only platform with all the information you need to Study Abroad | $2.5M / Seed / Jul 29, 2024 | |
Quantmatix
|
Quantmatix is a systematic data-driven software platform that assists professional investors in evaluating stock and asset selection, dynamically constructing portfolios, and driving performance. | $2.9M / Seed / Mar 21, 2024 | |
FeelTect
|
FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $1.6M / Dec 20, 2023 | |
|
FeelTect
|
FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $1.6M / Seed / Dec 20, 2023 | |
GREYSCOUT
|
GreyScout protects your brand against online counterfeits, rogue websites, grey market operators, unauthorized resellers and more | $3.7M / Seed / Nov 09, 2023 | |
| See all 71 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does HBAN invest in?
HBAN invests primarily in Software, Health Care and Medical Device startups, most often at Seed and Funding Round stage. Most of the 71 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is HBAN's check size?
HBAN typically joins rounds of $623k–$3.5M at Seed and $1.2M–$9.2M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HBAN participates in.
How do I contact HBAN?
Public channels for HBAN include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HBAN?
The team at HBAN includes Anthony Bermingham (Investor), Brendan McKittrick (Chairman) and John Phelan (National Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
